Guava and AHF Global Immunity bring low cost AIDS diagnosis to resource-limited...( HAYWARD CA (April 27 2005): Guava Tec...),Health

HAYWARD, CA (April 27, 2005): Guava Technologies, Inc., a privately held biotechnology and medical device company, and AHF Global Immunity, an international initiative of AIDS Healthcare Foundation, the largest specialized provider of HIV/AIDS medical care in the United States, today announced a partnership aimed at increasing access in resource-limited nations to AIDS diagnosis and treatment monitoring. The partnership will initially focus on making Guava's EasyCD4^TM system for direct, absolute CD4 T cell counts available at five sites in rural locations in Uganda and South Africa. Once the feasibility of using the Guava EasyCD4 system in these regions is demonstrated, AHF Global Immunity and Guava Technologies plan to cooperate in more broadly incorporating the Guava EasyCD4 testing system's use in HIV/AIDS clinics around the world.

"Accurate monitoring of CD4+ T lymphocyte levels in HIV infected individuals is a critical element for the use of anti-retroviral drugs, as it guides physicians in determining when to begin drug treatment and is a key measure of the effectiveness of that therapy," said Henry Chang, executive director, AHF Global Immunity. "With many resource-limited areas of the world now gaining access to more affordable anti-retroviral drugs, accurate but simpler, more portable and less costly methods of CD4+ testing are urgently needed. We are pleased to collaborate with Guava Technologies to bring such testing to several regions of Africa where the need is especially great."

"Until now, the cost of commercially available CD4 diagnostic testing for patient monitoring has remained very high, and access to affordable, accurate testing methods especially in areas outside of major urban centers very low," said Jeff Harvey, vice president of customer solutions at Guava Technologies. "Multi-site clinical studies suggest that CD4 T cell enumeration conducted on the Guava EasyCD4^TM represents a good, significantly low
'"/>

Contact: Joan Kureczka
jkureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
27-Apr-2005

Page: 1 2 3
Related medicine news :

1. Global warmings threat to New York region and how to avoid severe consequences
2. Global integration package welcome news
3. Global Fund must fund salaries of health workers to deliver HIV, TB and malaria treatments
4. Global burden of childhood deafness overlooked
5. Emory University announces new Global Health Institute
6. Global strategies to improve health in developing countries need truly global discussions
7. Global malaria map key weapon in fight against malaria, scientists say
8. Global Environmental Change and Human Health: New project launched at GEC Conference in Beijing
9. Global warming and your health
10. Global view shows strong link between kidney cancer, sunlight exposure
11. Global study shows all tobacco bad for the heart